News

HealtNewest updates you on health,nutrition, lifestyle, fitness, diet, cancer, medicine, disease, wound care, beauty products, and other healthy living topics.

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Editor’s note: This article has been provided by The Doctors Company, the exclusively endorsed medical malpractice carrier for the Society of Hospital Medicine. The pandemic has raised pressing questions around preventive measures, vaccines, and safe treatment, but it has also obscured
0 Comments
An advisory panel at the U.S. Centers for Disease Control and Prevention (CDC) has recommended a third dose of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and for some adults with underlying medical conditions that put them at risk of severe disease. But the panel declined to make the same recommendation — an additional booster after
0 Comments
Ways to reduce the risk of violence from firearms by people with dementia were described during a webinar hosted earlier this week by the BulletPoints Project, an initiative that was authorized and funded by California’s state legislature in collaboration with the University of California. Five million Americans, or 1.6% of the population, have Alzheimer’s dementia
0 Comments
A Santa Barbara County doctor who refuses to get vaccinated against COVID-19 is speaking out against the statewide requirement for health care workers to provide proof of vaccination starting Sept. 30. Vaccine Hesitancy Among Medical Professionals Hematologist and oncologist Dr. Mark Abate is one of the few medical practitioners who chose to remain unvaccinated despite the
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Remdesivir (Veklury, Gilead) was found to reduce some COVID-19 patients’ risk of hospitalization by 87% in a phase 3 trial, the drug’s manufacturer announced Wednesday in a press release. Cardiologist Robert L. Gottlieb, MD, PhD, from Baylor University Medical Center in
0 Comments
LDL cholesterol (LDL-C) exposure in younger adulthood predicted later cardiovascular events independent of cholesterol in middle age, large observational cohorts showed. Coronary heart disease significantly correlated with cumulative LDL-C (HR 1.57, P=0.01 for trend) as well as time-weighted average LDL (HR 1.69, P<0.001 for trend) across four studies and a median of 16 years of
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The U.S. will lift travel restrictions in November for international travelers who are fully vaccinated against COVID-19, including visitors from the U.K. and European Union, according to CNBC. The White House announced Monday that visitors will be required to show proof
0 Comments
The FDA granted accelerated approval to tisotumab vedotin-tftv (Tivdak), a first-in-class drug, for the treatment of patients with recurrent or metastatic cervical cancer, drugmakers Seagen and Genmab announced. Tisotumab vedotin, a tissue factor-directed antibody and microtubule inhibitor conjugate, is indicated for women whose disease progressed on or following chemotherapy. Approval was based on findings from
0 Comments
The COVID-19 pandemic is far from over, but the official death toll has already surpassed the estimated fatalities from the 1918 influenza outbreak, making it the deadliest health crisis in recent American history.  Influenza Outbreak vs. COVID-19 Pandemic Johns Hopkins University reported on its website Monday that the deaths in the country due to COVID-19
0 Comments
Adjuvant pembrolizumab (Keytruda) following complete melanoma resection could soon move to an earlier stage in the management of high-risk disease, suggest results from KEYNOTE 716. However, the results raise many questions, says an expert invited to discuss the new data. Adjuvant pembrolizumab is already approved in the USA for use in patients with melanoma with
0 Comments